Madrigal Pharmaceuticals Short Long Term Debt Total vs Total Assets

MDGL Stock

USD 355.88 46.39 14.99%

Madrigal Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Madrigal Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Madrigal Pharmaceuticals is a good investment. Please check the relationship between Madrigal Pharmaceuticals Short Long Term Debt Total and its Total Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Madrigal Pharmaceuticals Short Long Term Debt Total account and Total Assets. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Madrigal Pharmaceuticals' Short Long Term Debt Total and Total Assets is 0.14. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Total Assets in the same time period over historical financial statements of Madrigal Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Madrigal Pharmaceuticals' Short Long Term Debt Total and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of Madrigal Pharmaceuticals are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Short Long Term Debt Total i.e., Madrigal Pharmaceuticals' Short Long Term Debt Total and Total Assets go up and down completely randomly.

Correlation Coefficient

0.14

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Most indicators from Madrigal Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Madrigal Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.At this time, Madrigal Pharmaceuticals' Selling General Administrative is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 75.06 this year, although Enterprise Value Over EBITDA will most likely fall to (13.63).

	Total Assets	Total Stockholder Equity	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Common Stock	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Short Term Investments	Other Current Assets	Property Plant And Equipment Gross	Total Current Assets	Short Long Term Debt Total	Non Current Liabilities Total	Short Term Debt	Net Receivables
Total Assets		0.98	-0.3	0.85	0.93	0.5	-0.37	0.88	0.87	0.74	-0.27	-0.21	-0.81	0.87	0.24	0.81	0.41	1.0	0.97	0.89	0.45	1.0	0.14	0.84	-0.42	0.67
Total Stockholder Equity	0.98		-0.33	0.85	0.85	0.37	-0.4	0.78	0.77	0.67	-0.28	-0.3	-0.7	0.77	0.3	0.75	0.39	0.98	0.97	0.84	0.37	0.98	0.02	0.73	-0.46	0.7
Common Stock Total Equity	-0.3	-0.33		-0.57	-0.04	-0.2	1.0	-0.24	-0.18	-0.23	-0.2	0.29	-0.09	-0.2	-0.3	-0.11	-0.25	-0.34	-0.29	-0.11	-0.27	-0.32	-0.05	-0.17	0.82	-0.76
Common Stock Shares Outstanding	0.85	0.85	-0.57		0.72	0.57	-0.61	0.8	0.76	0.5	-0.38	-0.33	-0.59	0.72	0.37	0.49	0.53	0.87	0.79	0.61	0.32	0.85	0.19	0.64	-0.65	0.9
Other Stockholder Equity	0.93	0.85	-0.04	0.72		0.61	-0.11	0.94	0.96	0.77	-0.31	-0.01	-0.97	0.95	0.07	0.85	0.37	0.91	0.87	0.91	0.48	0.92	0.25	0.91	-0.19	0.46
Total Liab	0.5	0.37	-0.2	0.57	0.61		-0.21	0.73	0.72	0.44	-0.25	0.07	-0.69	0.67	0.14	0.31	0.47	0.52	0.4	0.29	0.52	0.49	0.84	0.76	-0.21	0.37
Common Stock	-0.37	-0.4	1.0	-0.61	-0.11	-0.21		-0.29	-0.24	-0.28	-0.19	0.29	-0.03	-0.26	-0.3	-0.18	-0.25	-0.4	-0.35	-0.19	-0.3	-0.39	-0.04	-0.23	0.83	-0.79
Other Current Liab	0.88	0.78	-0.24	0.8	0.94	0.73	-0.29		0.99	0.77	-0.24	-0.01	-0.93	0.96	0.09	0.79	0.46	0.87	0.78	0.84	0.54	0.87	0.32	0.9	-0.34	0.58
Total Current Liabilities	0.87	0.77	-0.18	0.76	0.96	0.72	-0.24	0.99		0.78	-0.25	0.01	-0.95	0.98	0.07	0.81	0.43	0.86	0.78	0.86	0.54	0.87	0.32	0.91	-0.27	0.53
Property Plant And Equipment Net	0.74	0.67	-0.23	0.5	0.77	0.44	-0.28	0.77	0.78		0.27	0.27	-0.75	0.78	-0.24	0.93	0.39	0.75	0.76	0.8	0.87	0.76	0.17	0.79	-0.22	0.3
Current Deferred Revenue	-0.27	-0.28	-0.2	-0.38	-0.31	-0.25	-0.19	-0.24	-0.25	0.27		0.14	0.28	-0.21	-0.18	0.08	-0.31	-0.23	-0.2	-0.13	0.45	-0.22	-0.13	-0.16	-0.12	-0.25
Net Debt	-0.21	-0.3	0.29	-0.33	-0.01	0.07	0.29	-0.01	0.01	0.27	0.14		-0.12	-0.01	-0.97	0.16	0.15	-0.23	-0.12	-0.03	0.41	-0.21	0.14	0.06	0.31	-0.37
Retained Earnings	-0.81	-0.7	-0.09	-0.59	-0.97	-0.69	-0.03	-0.93	-0.95	-0.75	0.28	-0.12		-0.94	0.04	-0.81	-0.33	-0.79	-0.73	-0.84	-0.51	-0.8	-0.35	-0.91	0.05	-0.3
Accounts Payable	0.87	0.77	-0.2	0.72	0.95	0.67	-0.26	0.96	0.98	0.78	-0.21	-0.01	-0.94		0.08	0.83	0.31	0.85	0.79	0.88	0.52	0.87	0.28	0.91	-0.26	0.51
Cash	0.24	0.3	-0.3	0.37	0.07	0.14	-0.3	0.09	0.07	-0.24	-0.18	-0.97	0.04	0.08		-0.17	-0.09	0.27	0.14	0.0	-0.32	0.24	0.1	0.06	-0.31	0.38
Non Current Assets Total	0.81	0.75	-0.11	0.49	0.85	0.31	-0.18	0.79	0.81	0.93	0.08	0.16	-0.81	0.83	-0.17		0.31	0.79	0.8	0.94	0.66	0.82	-0.01	0.79	-0.12	0.29
Non Currrent Assets Other	0.41	0.39	-0.25	0.53	0.37	0.47	-0.25	0.46	0.43	0.39	-0.31	0.15	-0.33	0.31	-0.09	0.31		0.42	0.38	0.21	0.48	0.4	0.24	0.32	-0.12	0.35
Cash And Short Term Investments	1.0	0.98	-0.34	0.87	0.91	0.52	-0.4	0.87	0.86	0.75	-0.23	-0.23	-0.79	0.85	0.27	0.79	0.42		0.97	0.86	0.48	1.0	0.17	0.84	-0.46	0.69
Short Term Investments	0.97	0.97	-0.29	0.79	0.87	0.4	-0.35	0.78	0.78	0.76	-0.2	-0.12	-0.73	0.79	0.14	0.8	0.38	0.97		0.85	0.5	0.97	0.08	0.78	-0.41	0.63
Other Current Assets	0.89	0.84	-0.11	0.61	0.91	0.29	-0.19	0.84	0.86	0.8	-0.13	-0.03	-0.84	0.88	0.0	0.94	0.21	0.86	0.85		0.43	0.89	-0.11	0.78	-0.23	0.45
Property Plant And Equipment Gross	0.45	0.37	-0.27	0.32	0.48	0.52	-0.3	0.54	0.54	0.87	0.45	0.41	-0.51	0.52	-0.32	0.66	0.48	0.48	0.5	0.43		0.48	0.38	0.6	-0.18	0.14
Total Current Assets	1.0	0.98	-0.32	0.85	0.92	0.49	-0.39	0.87	0.87	0.76	-0.22	-0.21	-0.8	0.87	0.24	0.82	0.4	1.0	0.97	0.89	0.48		0.13	0.84	-0.43	0.67
Short Long Term Debt Total	0.14	0.02	-0.05	0.19	0.25	0.84	-0.04	0.32	0.32	0.17	-0.13	0.14	-0.35	0.28	0.1	-0.01	0.24	0.17	0.08	-0.11	0.38	0.13		0.53	0.0	0.05
Non Current Liabilities Total	0.84	0.73	-0.17	0.64	0.91	0.76	-0.23	0.9	0.91	0.79	-0.16	0.06	-0.91	0.91	0.06	0.79	0.32	0.84	0.78	0.78	0.6	0.84	0.53		-0.24	0.43
Short Term Debt	-0.42	-0.46	0.82	-0.65	-0.19	-0.21	0.83	-0.34	-0.27	-0.22	-0.12	0.31	0.05	-0.26	-0.31	-0.12	-0.12	-0.46	-0.41	-0.23	-0.18	-0.43	0.0	-0.24		-0.85
Net Receivables	0.67	0.7	-0.76	0.9	0.46	0.37	-0.79	0.58	0.53	0.3	-0.25	-0.37	-0.3	0.51	0.38	0.29	0.35	0.69	0.63	0.45	0.14	0.67	0.05	0.43	-0.85

Click cells to compare fundamentals

High Positive Relationship

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Current Liabilities	+ 0.99	Other Current Liab
Total Stockholder Equity	+ 0.98	Total Assets

High Negative Relationship

Cash	- 0.97	Net Debt
Retained Earnings	- 0.97	Other Stockholder Equity
Retained Earnings	- 0.95	Total Current Liabilities
Accounts Payable	- 0.94	Retained Earnings
Retained Earnings	- 0.93	Other Current Liab
Non Current Liabilities Total	- 0.91	Retained Earnings

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	287.0M	273.3M	362.6M	640.5M	1.0B	1.1B
Total Stockholder Equity	240.0M	196.1M	197.4M	405.3M	754.4M	792.1M
Common Stock Shares Outstanding	15.4M	16.5M	17.1M	18.7M	21.3M	22.3M
Liabilities And Stockholders Equity	287.0M	273.3M	362.6M	640.5M	1.0B	1.1B
Other Stockholder Equity	665.4M	863.5M	1.2B	1.7B	2.6B	2.7B
Total Liab	47.0M	77.2M	165.2M	235.2M	118.6M	59.7M
Other Current Liab	44.9M	54.6M	91.5M	90.0M	124.7M	130.9M
Total Current Liabilities	46.6M	76.8M	115.9M	118.5M	169.3M	177.7M
Property Plant And Equipment Net	1.8M	1.6M	1.2M	3.3M	4.6M	4.8M
Net Debt	(53.2M)	(35.5M)	(281.7M)	17.3M	(99.0M)	(104.0M)
Retained Earnings	(425.5M)	(667.3M)	(962.7M)	(1.3B)	(1.8B)	(1.7B)
Accounts Payable	1.0M	21.4M	23.8M	28.0M	43.6M	45.8M
Cash	54.0M	36.3M	331.5M	99.9M	100.0M	100.2M
Non Current Assets Total	1.8M	1.6M	1.2M	3.3M	9.3M	9.8M
Non Currrent Assets Other	1.9M	1.8M	797K	1.2M	1.4M	719.9K
Cash And Short Term Investments	284.1M	270.3M	358.8M	634.1M	926.3M	972.6M
Short Term Investments	230.1M	234.1M	27.2M	534.2M	826.2M	867.5M
Other Current Assets	2.0M	2.7M	2.6M	3.2M	18.8M	19.7M
Property Plant And Equipment Gross	1.8M	1.6M	1.2M	3.3M	2.9M	2.1M
Total Current Assets	285.2M	271.7M	361.4M	637.3M	1.0B	1.1B
Accumulated Other Comprehensive Income	47K	(80K)	(32K)	468K	Updating Transaction... Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions Feedback Blog Made with optimal in San Francisco 2024 Macroaxis LLC COMMON DESTINATIONS My Portfolios Thematic Proposal Market Map Investment Tools Equity Filter ETFs Funds Companies Insiders Buy or Sell Advice Correlations Patterns Technical Analysis Risk-Return Landscape Investing Ideas Portfolio Center Financial Advisers Economic Indicators MAIN CATEGORIES Portfolio Optimization Equity Research Economic Indicators Watchlist Tools AI Investment Finder FinTech Suite Market Snapshot Latest Stories Investing Sectors AI Portfolio Architect Financial Widgets COMPANY Macroaxis Sign-In Home About Us Contact Us Quick Product Tour FAQs Privacy Policy Terms Of Use Plan & Pricing

Madrigal Short Long Term Debt Total vs Total Assets Analysis

Short Long Term Debt Total vs Total Assets

Short Long Term Debt Total vs Total Assets Correlation Analysis

Correlation Coefficient

Short Long Term Debt Total

Total Assets

Madrigal Pharmaceuticals fundamental ratios Correlations

Madrigal Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Madrigal Pharmaceuticals fundamental ratios Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY